Lebwohl David 的 Form 4 申報
Intellia Therapeutics, Inc.（NTLA），2021/9/1 申報
- 申報編號
- 0001209191-21-054317
- 申報時間
- 2021/9/1
- 交易日
- 2021/8/30
- 申報延遲
- 2 天
- 10b5-1 計畫
- 表單沒有這欄（2023 年以前）
這份申報列了 6 筆非衍生性交易、1 筆衍生性交易。公開市場賣出合計 $37.9 萬。交易後 2 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Lebwohl DavidCIK 0001810882 | 高階主管（執行副總裁、醫療長） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2021/8/30 | Common Stock | M行使選擇權取得 | +2,400 | $12.62 | +$30,288 | 3,191 | 直接 | |
| 2021/8/30 | Common Stock | S賣出處分 | −200 | $155.43F2 | −$31,086 | 2,991 | 直接 | |
| 2021/8/30 | Common Stock | S賣出處分 | −700 | $156.70F3 | −$109,690 | 2,291 | 直接 | |
| 2021/8/30 | Common Stock | S賣出處分 | −250 | $157.60F4 | −$39,400 | 2,041 | 直接 | |
| 2021/8/30 | Common Stock | S賣出處分 | −1,100 | $159.19F5 | −$175,109 | 941 | 直接 | |
| 2021/8/30 | Common Stock | S賣出處分 | −150 | $160.10F6 | −$24,015 | 791 | 直接 |
衍生性證券（表 II）
選擇權、認股權證、限制型股票單位等。股數是標的股票的股數；單價與金額是衍生證券本身的價格，交易後持有是衍生證券的單位數。
| 交易日 | 證券 | 交易 | 標的股數 | 單價 | 金額 | 交易後持有 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2021/8/30 | Common Stock | M行使選擇權處分 | −2,400 | $0.00 | $0 | 195,200 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $155.10 to $155.76, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 30, 2021 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F3
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $156.29 to $157.13, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 30, 2021 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F4
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $157.29 to $157.89, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 30, 2021 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F5
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $158.55 to $159.50, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 30, 2021 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F6
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $160.02 to $160.97, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 30, 2021 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。